Aptamer Group develops custom affinity binders using its proprietary Optimer® platform. Optimer binders are used as antibody alternatives in therapeutics, diagnostics, bioprocessing and analytical applications. The Optimer platform consists of three parallel processes optimized for target type to enable scientists with the best affinity ligand for small molecules, proteins or cell targets. Offering rapid development in just weeks, controlled and tuneable binding kinetics to ensure desired end-use performance, Optimer binders are engineered to remove barriers to innovation across the life sciences.

Aptamer Group 利用其专有的 Optimer® 平台开发定制亲和性结合分子 (affinity binder)。Optimer 结合分子可作为抗体替代品，应用于治疗、诊断、生物加工和分析领域。Optimer 平台包含三个并行流程，并针对靶标类型进行了优化，使科学家能够针对小分子、蛋白质或细胞靶标找到最佳的亲和力配体。Optimer 结合分子可在短短数周内快速开发，其结合动力学可控且可调，以确保达到所需的最终使用性能，旨在消除生命科学领域创新的障碍。